BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 47.23
0.00 (0.00%)
At close: Oct 10, 2025
BridgeBio Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 748.95 | 681.1 | 375.94 | 376.69 | 393.77 | 356.08 | Upgrade |
Short-Term Investments | 7.94 | - | 58.95 | 95.23 | 442.89 | 251.01 | Upgrade |
Cash & Short-Term Investments | 756.89 | 681.1 | 434.88 | 471.92 | 836.66 | 607.09 | Upgrade |
Cash Growth | 69.04% | 56.62% | -7.85% | -43.59% | 37.81% | 11.19% | Upgrade |
Accounts Receivable | 76.87 | 4.72 | 1.75 | 17.08 | 19.75 | - | Upgrade |
Total Trade Receivables | 76.87 | 4.72 | 1.75 | 17.08 | 19.75 | - | Upgrade |
Inventory | 18.28 | - | - | - | - | - | Upgrade |
Other Current Assets | 60.24 | 34.87 | 40.96 | 59.85 | 32.45 | 35.73 | Upgrade |
Total Current Assets | 912.28 | 720.69 | 477.59 | 548.85 | 888.86 | 642.82 | Upgrade |
Net Property, Plant & Equipment | 12.29 | 12.78 | 19.84 | 25.25 | 45.97 | 36.83 | Upgrade |
Other Intangible Assets | 29.51 | 23.93 | 26.32 | 28.71 | 44.93 | - | Upgrade |
Long-Term Investments | 108 | 143.75 | - | - | - | - | Upgrade |
Other Long-Term Assets | 18.11 | 18.2 | 22.63 | 20.22 | 33.03 | 23.93 | Upgrade |
Total Assets | 1,080 | 919.34 | 546.38 | 623.04 | 1,013 | 703.59 | Upgrade |
Accounts Payable | 26.13 | 9.62 | 10.66 | 11.56 | 11.88 | 8.95 | Upgrade |
Accrued Expenses | 68.48 | 92.6 | 122.97 | 98.04 | 118.25 | 75.9 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | - | 1.46 | Upgrade |
Current Portion of Leases | 4.78 | 4.51 | 4.13 | 3.68 | 4.94 | 3.8 | Upgrade |
Unearned Revenue | 10.54 | 14.6 | 6.1 | 8.16 | - | - | Upgrade |
Other Current Liabilities | 65.92 | 33.07 | - | - | - | 5.55 | Upgrade |
Total Current Liabilities | 175.85 | 154.4 | 143.84 | 121.43 | 135.07 | 95.65 | Upgrade |
Long-Term Debt | 1,850 | 1,721 | 1,727 | 1,708 | 1,704 | 475.86 | Upgrade |
Long-Term Leases | 4.03 | 4.7 | 8.98 | 12.27 | 17.43 | 14.68 | Upgrade |
Other Long-Term Liabilities | 829.17 | 496.47 | 9.36 | 26.64 | 22.07 | 9.52 | Upgrade |
Total Long-Term Liabilities | 2,683 | 2,223 | 1,745 | 1,747 | 1,743 | 500.05 | Upgrade |
Total Liabilities | 2,859 | 2,377 | 1,889 | 1,868 | 1,878 | 595.7 | Upgrade |
Common Stock | 0.2 | 0.2 | 0.18 | 0.16 | 0.15 | 0.13 | Upgrade |
Treasury Stock | -323.28 | -275 | -275 | -275 | -275 | -75 | Upgrade |
Additional Paid-in Capital | 1,981 | 1,903 | 1,481 | 938.7 | 841.53 | 1,021 | Upgrade |
Accumulated Other Comprehensive Income | 0 | 0.01 | 0.03 | -0.33 | -0.13 | 0.19 | Upgrade |
Retained Earnings | -3,446 | -3,096 | -2,561 | -1,918 | -1,437 | -888.76 | Upgrade |
Total Common Shareholders' Equity | -1,788 | -1,468 | -1,354 | -1,255 | -870.41 | 57.91 | Upgrade |
Minority Interest | 9.44 | 10.29 | 11.72 | 9.69 | 4.84 | 49.98 | Upgrade |
Shareholders' Equity | -1,778 | -1,458 | -1,343 | -1,243 | -867 | 106.26 | Upgrade |
Total Liabilities & Equity | 1,080 | 919.34 | 546.38 | 623.04 | 1,013 | 703.59 | Upgrade |
Total Debt | 1,858 | 1,731 | 1,740 | 1,724 | 1,726 | 495.79 | Upgrade |
Net Cash (Debt) | -1,101 | -1,049 | -1,305 | -1,252 | -889.51 | 111.31 | Upgrade |
Net Cash Growth | - | - | - | - | - | -75.49% | Upgrade |
Net Cash Per Share | -5.81 | -5.64 | -8.02 | -8.49 | -6.16 | 0.94 | Upgrade |
Book Value | -1,788 | -1,468 | -1,354 | -1,255 | -870.41 | 57.91 | Upgrade |
Book Value Per Share | -9.43 | -7.89 | -8.32 | -8.51 | -6.03 | 0.49 | Upgrade |
Tangible Book Value | -1,817 | -1,492 | -1,381 | -1,283 | -915.35 | 57.91 | Upgrade |
Tangible Book Value Per Share | -9.58 | -8.02 | -8.48 | -8.70 | -6.34 | 0.49 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.